Social Anxiety Disorder
📧 Sign up to get email alerts when something new happens for Social Anxiety Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-10-31FDA Approved: PAROXETINE — Original Application (Solco Healthcare US, LLC)
FDA approved Solco Healthcare US, LLC's original ANDA for paroxetine hydrochloride hemihydrate (paroxetine), making a generic version of the…
-
FDA approval · 2014-10-27FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for sertraline hydrochloride, a generic version of sertraline. This action …
-
FDA approval · 2014-10-21FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Effexor XR (venlafaxine extended-release) submitted by Viatris Specialty LLC.
-
CLINICAL_TRIALS trial_result · 2014-10-08Clinical Trial Update: 12-Week Study of Pristiq (Desvenlafaxine) Social Anxiety Disorder [Phase 4]
Phase 4 study of desvenlafaxine (Pristiq) for social anxiety disorder has completed. Results were posted on October 8, 2014.
-
FDA approval · 2014-09-19FDA Approved: VENLAFAXINE — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approved a supplemental application for venlafaxine by Alembic Pharmaceuticals, enabling a generic venlafaxine product through an ANDA s…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-09-12FDA Approved: ZOLOFT — Supplemental Application (ROERIG)
The FDA approved a supplemental application for Zoloft (sertraline hydrochloride) submitted by Roerig.
-
CLINICAL_TRIALS trial_result · 2014-08-21Clinical Trial Update: Quetiapine in Co-Morbid Depressive and Anxiety Disorders [NA]
A completed clinical trial evaluating quetiapine for co-morbid depressive and anxiety disorders, including major depressive disorder, dysthy…
-
CLINICAL_TRIALS trial_result · 2014-08-15Clinical Trial Update: Effect of Oxytocin Nasal Sprays on Social Behavior in Social Anxiety Disorder [Phase 1, Phase 2]
Phase 1/2 trial assessing oxytocin nasal spray effects on social behavior in individuals with social anxiety disorder; study completed with …
-
CLINICAL_TRIALS trial_result · 2014-08-12Clinical Trial Update: Internet Treatment for Social Phobia in Romania [NA]
A completed clinical trial in Romania evaluated internet-based treatment for social phobia (social anxiety disorder); results were posted on…
-
CLINICAL_TRIALS research · 2014-08-01Clinical Trial Update: An Open Label, Double-blind Discontinuation Study of Quetiapine Extended Release(XR) [EARLY_Phase 1]
An early-phase open-label, double-blind discontinuation study of quetiapine XR for social anxiety disorder; the trial has been terminated.
-
CLINICAL_TRIALS research · 2014-07-21Clinical Trial Update: Attention Retraining for Anxiety Disorder Patients Resistent to Antidepressants [NA]
This clinical trial update describes a study on attention retraining for anxiety disorder patients who have not responded to antidepressants…
-
FDA label_change · 2014-07-18FDA Approved: VENLAFAXINE — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for Venlafaxine from BluePoint Laboratories. The update concerns this generic product's regulatory s…
-
CLINICAL_TRIALS research · 2014-07-18Clinical Trial Update: Transdisciplinary Studies of CBT for Anxiety in Youth: Child Anxiety Treatment Study [NA]
A completed clinical trial evaluating cognitive-behavioral therapy for anxiety in youth, covering generalized anxiety disorder, separation a…
-
FDA approval · 2014-07-17FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for venlafaxine hydrochloride from Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2014-07-17FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for venlafaxine hydrochloride (generic) from Dr. Reddy's Laboratories Limited. This action approves …
-
FDA approval · 2014-07-17FDA Approved: VENLAFAXINE — Supplemental Application (Alembic Pharmaceuticals Inc.)
The FDA approved Alembic Pharmaceuticals' supplemental application for a generic venlafaxine product (ANDA 078932). Venlafaxine is indicated…
-
FDA approval · 2014-07-17FDA Approved: VENLAFAXINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Venlafaxine hydrochloride, a generic venlafaxine product from Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2014-07-02Clinical Trial Update: Special Drug Use Investigation for PAXIL (Paroxetine) Social Anxiety Disorder (Long-term)
A completed long-term Special Drug Use Investigation evaluating paroxetine (Paxil) for social anxiety disorder.
-
FDA approval · 2014-06-30FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for venlafaxine hydrochloride from Teva Pharmaceuticals USA, Inc., marking an approval action un…
-
FDA approval · 2014-06-26FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approves a supplemental application for venlafaxine hydrochloride from Dr. Reddy's Laboratories Limited.
-
FDA approval · 2014-06-26FDA Approved: VENLAFAXINE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
The FDA approved a supplemental application for venlafaxine submitted by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
-
FDA approval · 2014-06-18FDA Approved: VENLAFAXINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Venlafaxine hydrochloride from Aurobindo Pharma Limited.
-
FDA approval · 2014-06-17FDA Approved: VENLAFAXINE — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for venlafaxine from BluePoint Laboratories under ANDA077653. This action authorizes a generic versi…
-
CLINICAL_TRIALS trial_result · 2014-06-02Clinical Trial Update: Exposure With Acceptance-Based Versus Habituation-Based Rationale for Public Speaking Anxiety [NA]
The study evaluated two behavioral approaches for public speaking anxiety (acceptance-based exposure versus habituation-based exposure); it …
-
CLINICAL_TRIALS trial_result · 2014-05-20Clinical Trial Update: Use of an Antibiotic as an Enhancer for the Treatment of Social Phobia [Phase 2]
A Phase 2 clinical trial evaluating an antibiotic as an enhancer to treat social anxiety disorder has completed, with results posted in 2014…